{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:34:30Z","timestamp":1792892070526,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Visceral leishmaniasis is a parasitic infection caused by <jats:italic>Lesihmania donovani<\/jats:italic> complex and transmitted by the bite of the <jats:italic>phlebotomine<\/jats:italic> sand fly. It is an endemic disease in many developing countries with more than 90% of the cases occurring in Bangladesh, India, Nepal, Sudan, Ethiopia and Brazil. The disease is fatal if untreated. The disease is conventionally diagnosed by demonstrating the intracellular parasite in bone marrow or splenic aspirates. This study was carried out to discover differentially expressed proteins which could be potential biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Sera from six visceral leishmaniasis patients and six healthy controls were depleted of high abundant proteins by immunodepletion. The depleted sera were compared by 2-D Difference in gel electrophoresis (DIGE). Differentially expressed proteins were identified the by tandem mass spectrometry. Three of the identified proteins were further validated by western blotting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This is the first report of serum proteomics study using quantitative Difference in gel electrophoresis (DIGE) in visceral leishmaniasis. We identified alpha-1-acidglycoprotein and C1 inhibitor as up regulated and transthyretin, retinol binding protein and apolipoprotein A-I as down regulated proteins in visceral leishmaniasis sera in comparison with healthy controls. Western blot validation of C1 inhibitor, transthyretin and apolipoprotein A-I in a larger cohort (n = 29) confirmed significant difference in the expression levels (p &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In conclusion, DIGE based proteomic analysis showed that several proteins are differentially expressed in the sera of visceral leishmaniasis. The five proteins identified here have potential, either independently or in combination, as prognostic biomarkers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1559-0275-8-4","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T15:30:40Z","timestamp":1324308640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients"],"prefix":"10.1186","volume":"8","author":[{"given":"Lokesh A","family":"Rukmangadachar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gururao","family":"Hariprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotish C","family":"Samantaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alagiri","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P: Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004, 27: 305-18. 10.1016\/j.cimid.2004.03.004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","volume":"5","author":"F Chappuis","year":"2005","unstructured":"Chappuis F, Sundar S, Hailu A: Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat Rev Microbiol. 2005, 5: 873-82.","journal-title":"Nat Rev Microbiol"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/CDLI.8.6.1220-1224.2001","volume":"8","author":"R Kumar","year":"2007","unstructured":"Kumar R, Pai K, Pathak K, Sundar S: Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis. Clin Diagn Lab Immunol. 2007, 8: 1220-24.","journal-title":"Clin Diagn Lab Immunol"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/JCM.02029-06","volume":"45","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin JC: Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications. J Clin Microbiol. 2007, 45: 21-25. 10.1128\/JCM.02029-06","journal-title":"J Clin Microbiol"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1002\/pmic.200600284","volume":"6","author":"S Hu","year":"2006","unstructured":"Hu S, Loo JA, Wong DT: Human body fluid proteome analysis. Proteomics. 2006, 6: 6326-53. 10.1002\/pmic.200600284","journal-title":"Proteomics"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/bmj.1.5131.1221","volume":"9","author":"A Shanker","year":"1959","unstructured":"Shanker A: Electrophoretic differential serum protein pattern in kala-azar. British Medical journal. 1959, 9: 1221-23.","journal-title":"British Medical journal"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1371\/journal.pone.0000040","volume":"1","author":"M Forgber","year":"2006","unstructured":"Forgber M, Basu R, Roychoudhury K: Mapping the antigenicity of the parasites in Leishmania donovani infection byproteome serology. PLoS One. 2006, 1: e40- 10.1371\/journal.pone.0000040","journal-title":"PLoS One"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1002\/pmic.200402021","volume":"5","author":"N Zolotarjova","year":"2005","unstructured":"Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes BE, Barrett WC: Differences among techniques for high-abundant protein depletion. Proteomics. 2005, 5: 3304-13. 10.1002\/pmic.200402021","journal-title":"Proteomics"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1074\/mcp.M300026-MCP200","volume":"2","author":"LF Steel","year":"2003","unstructured":"Steel LF, Trotter MG, Nakajima PB, Mattu TS, Gonye G, Block T: Efficient and specific removal of albumin from human serum samples. Mol Cell Proteomics. 2003, 2: 262-70.","journal-title":"Mol Cell Proteomics"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1021\/pr060100p","volume":"5","author":"TH Corzett","year":"2006","unstructured":"Corzett TH, Fodor IK, Choi MW: Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis. J Proteome Res. 2006, 5: 2611-19. 10.1021\/pr060100p","journal-title":"J Proteome Res"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(04)16046-7","volume":"363","author":"MC Papadopoulos","year":"2004","unstructured":"Papadopoulos MC, Abel PM, Agranoff D: A novel and accurate diagnostic test for human African trypanosomiasis. Lancet. 2004, 363: 1358-63. 10.1016\/S0140-6736(04)16046-7","journal-title":"Lancet"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","volume":"368","author":"D Agranoff Fernandez-Reyes","year":"2006","unstructured":"Agranoff Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A: Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet. 2006, 368: 1012-21. 10.1016\/S0140-6736(06)69342-2","journal-title":"Lancet"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1021\/pr070223p","volume":"6","author":"N Gupta","year":"2006","unstructured":"Gupta N, Shankernarayan NP, Dharmalingam K: Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. J Proteome Res. 2006, 6: 3669-79.","journal-title":"J Proteome Res"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/eji.1830221032","volume":"22","author":"A Boutten","year":"1992","unstructured":"Boutten A, Dehoux M, Deschenes M, Rouzeau JD, Bories PN, Durand G: Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol. 1992, 22: 2687-95. 10.1002\/eji.1830221032","journal-title":"Eur J Immunol"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.180.4.1571","volume":"180","author":"C Libert","year":"1994","unstructured":"Libert C, Brouckaert P, Fiers W: Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med. 1994, 180: 1571-75. 10.1084\/jem.180.4.1571","journal-title":"J Exp Med"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/0035-9203(95)90442-5","volume":"89","author":"KM Wasunna","year":"1995","unstructured":"Wasunna KM, Raynes JG, Were JB: Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1995, 89: 678-81. 10.1016\/0035-9203(95)90442-5","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1016\/j.molimm.2008.06.028","volume":"45","author":"AE Davis III","year":"2008","unstructured":"Davis AE, Mejia P, Lu F: Biological activities of c1 inhibitor. Mol Immunol. 2008, 45: 4057-63. 10.1016\/j.molimm.2008.06.028","journal-title":"Mol Immunol"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1084\/jem.194.11.1609","volume":"194","author":"H Jiang","year":"2001","unstructured":"Jiang H, Wagner E, Zhang H, Frank MM: Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med. 2001, 194: 1609-16. 10.1084\/jem.194.11.1609","journal-title":"J Exp Med"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1753425909340420","volume":"16","author":"EB Thorgersen","year":"2010","unstructured":"Thorgersen EB, Ludviksen JK, Lambris JD, Sfyroera G, Nielsen EW, Mollnes TE: Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity. Innate Immun. 2010, 16: 254-64. 10.1177\/1753425909340420","journal-title":"Innate Immun"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/382752","volume":"189","author":"AK Chava","year":"2004","unstructured":"Chava AK, Chatterjee M, Sharma V, Sundar S, Mandal C: Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans. J Infect Dis. 2004, 189: 1257-64. 10.1086\/382752","journal-title":"J Infect Dis"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1517\/14656566.2.7.1073","volume":"2","author":"M Kirschfink","year":"2001","unstructured":"Kirschfink M, Mollnes TE: C1-inhibitor: an anti-inflammatory reagent with therapeutic potential. Expert Opin Pharmacother. 2001, 2: 1073-83. 10.1517\/14656566.2.7.1073","journal-title":"Expert Opin Pharmacother"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.molmed.2008.09.009","volume":"14","author":"L Beinrohr","year":"2008","unstructured":"Beinrohr L, Dob\u00f3 J, Z\u00e1vodszky P, G\u00e1l P: C1, MBL MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends Mol Med. 2008, 14: 511-21. 10.1016\/j.molmed.2008.09.009","journal-title":"Trends Mol Med"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1515\/CCLM.2007.333","volume":"45","author":"AM Johnson","year":"2007","unstructured":"Johnson AM, Merlini G, Sheldon J, Ichihara K: Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med. 2007, 45: 419-26. 10.1515\/CCLM.2007.051","journal-title":"Clin Chem Lab Med"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/PNS19890050","volume":"48","author":"A Fleck","year":"1989","unstructured":"Fleck A: Clinical and nutritional aspects of changes in acute-phase proteins during inflammation. Proc Nutr Soc. 1989, 48: 347-54. 10.1079\/PNS19890050","journal-title":"Proc Nutr Soc"},{"key":"3_CR25","first-page":"885","volume":"30","author":"P Bouree","year":"2000","unstructured":"Bouree P, Botterel F, Lancon A: Study of protein profile in the visceral leishmaniasis. J Egypt Soc Parasitol. 2000, 30: 885-93.","journal-title":"J Egypt Soc Parasitol"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/BF00918973","volume":"16","author":"L Borish","year":"1992","unstructured":"Borish L, King MS, Mascali JJ, Johnson S, Coll B, Rosenwasser LJ: Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production. Inflammation. 1992, 16: 471-84. 10.1007\/BF00918973","journal-title":"Inflammation"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1021\/bi982291i","volume":"38","author":"HM Naylor","year":"1999","unstructured":"Naylor HM, Newcomer ME: The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry. 1999, 38: 2647-53. 10.1021\/bi982291i","journal-title":"Biochemistry"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4269\/ajtmh.2008.79.591","volume":"79","author":"BL Maciel","year":"2008","unstructured":"Maciel BL, Lacerda HG, Queiroz JW: Association of nutritional status with the response to infection with Leishmania chagasi. Am J Trop Med Hyg. 2008, 79: 591-98.","journal-title":"Am J Trop Med Hyg"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ajcn\/51.4.638","volume":"51","author":"MS Mourey","year":"1990","unstructured":"Mourey MS, Siegenthaler G, Am\u00e9d\u00e9e-Manesme O: Regulation of metabolism of retinol-binding protein by vitamin A status in children with biliary atresia. Am J Clin Nutr. 1990, 51: 638-43.","journal-title":"Am J Clin Nutr"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0009-8981(89)90288-X","volume":"184","author":"D Bekaert","year":"1989","unstructured":"Bekaert D, Kallel R, Bouma ME: Plasma lipoproteins in infantile visceral leishmaniasis: deficiency of apolipoproteins A-I and A-II. Clin Chim Acta. 1989, 184: 181-91. 10.1016\/0009-8981(89)90288-X","journal-title":"Clin Chim Acta"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1388-1981(01)00081-6","volume":"1531","author":"GM Anantharamaiah","year":"2001","unstructured":"Anantharamaiah GM, Engler JA, Borhani DW: Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta. 2001, 1531: 4-46.","journal-title":"Biochim Biophys Acta"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1182\/blood.V97.8.2381","volume":"97","author":"N Hyka","year":"2001","unstructured":"Hyka N, Dayer J, Modoux C: Apolipoprotein A-I inhibits the production of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 by blocking contact-mediated activation of monocytes by T lymphocytes. Blood. 2001, 97: 2381-89. 10.1182\/blood.V97.8.2381","journal-title":"Blood"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1559-0275-8-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:53:54Z","timestamp":1630518834000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/1559-0275-8-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1186\/1559-0275-8-4","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]},"assertion":[{"value":"4 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}